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Macrophages are a major source of arachidonic acid (20:4) metabolites (1-7). 
Among these metabolites, prostaglandins (PG) ~ appear of particular interest in 
consideration of their proinflammatory properties (8, 9) and of their potential 
regulative  effects  on  the  immune response  through  their  actions  on  T  and 
possibly B lymphocytes (1,  10-13).  PG have also been implicated in feed-back 
regulation of macrophage activities (14-16). 
Under in vitro conditions, macrophages have to be triggered by inflammatory 
stimuli, either particulate (2,  17) or soluble substances (3,  18), to synthesize PG 
from their endogenous 20:4 and to release them in the culture medium. The 
subcellular events underlying this stimulation are  still poorly understood.  Re- 
garding immune complexes, binding to plasma membrane Fc receptors seems to 
be a sufficient stimulus for PG secretion (19). How the signal is transmitted from 
the cell surface to the enzymes acting in PG synthesis is still a pending question. 
On  the  basis  of electron  microscope  studies,  it  has  been  hypothesized  that 
membrane events bring together the lipid and enzyme constituents necessary for 
PG production (20). However, information on the macrophage enzymes involved 
in this process, particularly on their subcellular distribution, are still scarce. 
To investigate the question, we have developed a method to assay the activity 
of the enzyme system which converts arachidonic acid into PGE~ in homogenates 
and in subcellular fractions of mouse resident peritoneal (MRP) macrophages. 
Using this method, we have examined the distribution of PGE2 synthesis activity 
by  density  gradient  analysis.  The  centrifugation  behavior  indicates  that,  in 
unstimulated macrophage homogenates, PGE2 synthesis is largely associated with 
sedimentable elements derived from the endoplasmic reticulum. The meaning 
of this particular location on the mechanisms of induction of PGE2 synthesis at 
the subcellular level are examined. 
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Materials and Methods 
Harvest, Cultivation, a~d FractionatioJ~ of MRP Macrophages.  Female mice of the NMR1 
strain were used as a source of MRP macrophages throughout this work. Collection of 
peritoneal cells,  cultivation of adhering cells  for 24  h  in  Dulbecco's modified Eagle's 
medium supplemented with  15% inactivated calf serum and antibiotics (200 U/ml peni- 
cillin and 0.1  mg/ml streptomycin), cell disruption, differential centrifugation giving the 
cytoplasmic extract, and  density equilibrium  centrifugation of this extract in  a  linear 
gradient of sucrose were performed as described in a previous paper (21), with  minor 
modifications. The solutions used for cell disruption and density gradient centrifugation 
contained  0.15  mg/ml  catalase,  which  enhanced  PGE2  synthesis  in  various  ways  (see 
Results).  The experimental procedures were also adapted to assay  the  PGE2 synthesis 
activity in subcellular fractions within hours after cell breakage; in particular the time of 
centrifugation at 40,000 rev/min in the E-40 rotor (22) was reduced to 60 min. 
When specified, cytoplasmic extracts were supplemented with 70 t~g digitonin per mg 
protein and 15 mM sodium pyrophosphate, pH 8, before density equilibrium centrifuga- 
tion. In several experiments a particulate fraction was isolated by centrifuging cytoplasmic 
extracts for 30  rain at  40,000  rev/min in a  no. 40  rotor (Beckman  Instruments Inc., 
Spinco Div.,  Palo Alto, CA).  It is designated MLP because it contains the sedimentable 
material otherwise recovered separately in  the  M,  L, and P  fractions after differential 
centrifugation (21). 
Assay Methods.  The PGE,~ synthesis activity was assayed by incubation for 15 rain at 
37 °C in a shaking water bath. The reaction medium contained 7.5 nmol [ 1J4C]arachidonic 
acid, 6 #mol L-adrenaline, 30 mnol reduced glutathione, and 60 #tool phosphate buffer 
at pH 6.8, in a final volume of 0.3 ml. The reaction was started by addition of the enzyme 
in  0.1  ml,  and  stopped  by  0.15  ml  1  N  HCI.  Lipids  were  extracted  twice  in  2  mt 
ethylacetate. The solvent was evaporated under a stream of nitrogen. The dry residue 
was dissolved in 0.1  ml ethanol and spotted on plastic-backed silica gel plates. Thin-layer 
chromatography  was  developed  with  ethylacetate/acetic acid/2,2,4-trimethylpentane/ 
water (90:20:50:100, vol/vol, organic phase) according to Hamberg and Samuelsson (23). 
The PGE~ spots were located on the chromatogram by exposure to iodine vapor, or by 
autoradiography. They were excised from the plates for extraction of PG in acetone and 
measurement  of the  radioactivity  by  liquid  scintillation.  A  standard  (~H-labeled,  or 
nonradioactive PGE2) was added  to the incubation medium at the end of the enzyme 
reaction to determine the recovery of PG in  the samples counted. Tritium counts, or 
colorimetric assays  of PG  by  the  Zimmerman  reaction  (24)  performed according  to 
Takeguchi et al. (25) gave recovery values usually close to 50%. 
Protein  (26),  NAD  glycohydrolase (21),  galactosyltransferase (27),  sulfatase  C  (27), 
cytochrome c oxidase (27), and acid a-galactosidase (27) were assayed as described in the 
quoted articles. 
Materials.  [1J4C]arachidonic  acid  (50-60  mCi/mmol)  and  [5,6,8,11,12,14,15(n)- 
"~H]PGE~ (160 Ci/mmol) were purchased from The Radiocbemical Centre Ltd. (Amer- 
sham,  England).  Arachidonic acid,  PGE.~, superoxide dismutase,  hemoglobin, 3-amino- 
1,2,4-triazole, L-adrenaline bitartrate,  and  reduced  glutathione  were  products  of the 
Sigma Chemical Co. (St. Louis, MO). Precoated thin layer chromatography-plastic sheets 
silica gel 60 (thickness 0.2 mm) and digitonin were products of E. Merck A.G. (Darmstadt, 
Federal  Republic of Germany). The other  reagents  or products  have  been  described 
previously (21). 
Results 
PGE2 Synthesis by Cell-free Extracts of Cultivated MRP Macrophages.  On incuba- 
tion in the presence of L-adrenaline and reduced glutathione cytoplasmic extracts 
derived from  24  h  cultivated  MRP  macrophages converted [1J4C]arachidonic 
acid into several labeled products revealed on the thin layer chromatograms by 
autoradiography (Fig.  1).  The major reaction product accounted for ~-67%  of DARTE  AND  BEAUFAY  91 
FIC.URE  1.  Thin layer radiochromatography of the products formed from arachidonic acid 
by cytoplasmic extracts derived from cultivated MRP macrophages. Lane 1: the cytoplasmic 
extract (0.2 mg protein) was incubated with [1-~4C]arachidonic  acid as described in Materials 
and Methods. After 15 rain at 37°C the lipid material was extracted and chromatographed on 
silica gel. Labeled compounds were revealed by autoradiography. Arrows indicate the position 
of PGE,I and arachidonic acid (AA) standards revealed by exposure to iodine. Lane 2: control 
incubated exactly as the assay, except for the omission of the cytoplasmic extract. 
TABLE  | 
Inhibitio~ of the PGE,~ Sy~lthesis Activih' by Various Compounds 
Added compound  Concentration  PGE2 synthesis activity 
mM  pmol/min  × mg  % 
protei~t 
--  --  141  __-  16"  100 
Indomethacin  5 x  10 -4  11  8 
0.025  3  2 
Dithiothreitol  1.3  35  25 
5  54  38 
Triton X-100  0.5  56  40 
Triton X-405  0.5  124  88 
2.0  81  57 
* Mean _  SD of three preparations. 
the  label  associated  with  arachidonic  acid  derivatives  and  co-migrated  with 
authentic PGE2.  Consistent with this identification, synthesis of this product was 
abolished by indomethacin (Table I), a cyclooxygenase inhibitor (28). 
The  other  labeled  compounds  seen  after thin  layer chromatography were 
present in much smaller amounts. They have not been identified, but the two 
minor radioactive spots  found  between the origin and  PGE~  probably  reveal 
other products of the cyclooxygenase pathway, because their formation was also 
inhibited  by  indomethacin  (result  not  shown). Judging  from  their  respective 
position  on  the  chromatogram  these  compounds  may  be  6-keto  PGF1~ and 
PGF2~, in the order of decreasing polarity. Our subsequent studies were focused 
on PGEz synthesis because this prominent derivative was the only product formed 
in sufficient amount for quantitative assay. 
Kinetic  studies  were  carried  out  to  optimize  assay  conditions  for  enzyme 92  SUBCELLULAR  LOCALIZATION  OF  PROSTAGLANDIN  E~  SYNTHESIS 
activity, and for linearity of reaction with respect to incubation time and enzyme 
concentration.  The pH-dependency of PGE2 synthesis showed a  maximum  be- 
tween pH 6.5 and  7.5.  The activity was very low in the absence of adrenaline 
(Fig. 2). It rose with the concentration of adrenaline in a manner fairly consistent 
with a  Michaelis-Menten relationship when the activity in the absence of adren- 
aline was deduced from the other activity values. Adrenaline might thus act as a 
cosubstrate at some intermediate  step in the course of PGE2 synthesis.  In other 
systems adrenaline  and various aromatic compounds stimulate cyclooxygenase, 
presumably in donating electrons that  reduce the hydroperoxy group of PGGe 
into the hydroxyl of PGH2 (29-31). 
Glutathione also enhanced the PGEe synthesis activity; the effect was complex 
and showed a maximum at the concentration of 0.1  mM (Fig. 3). Glutathione is 
known  to  act  as a  cofactor for  isomerization  of PGH  into  PGE,  although  its 
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FIGURE 2.  Influence of L-adrenaline concentration on  PGE~  synthesis. An  MLP  fraction 
(0.25 mg protein) was incubated with 0.05 mM [1J4C]arachidonic acid, in the presence of 1 
mM reduced glutathione and L-adrenaline at the concentrations given in abscissa. Otherwise, 
PGE2 synthesis activity was assayed as described in Materials and Methods. Inset: Hofstee plot 
of the values corrected for the activity in the absence of adrenaline. 
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FIGURE 3.  Influence of reduced glutathione on PGE~ synthesis. An MLP fraction (0.22 mg 
protein) was incubated with 0.05  mM  [1-14C]arachidonic acid,  in  the presence of reduced 
glutathione at various concentrations (abscissa). Otherwise, PGE~ synthesis activity was assayed 
as described in Materials and Methods. DARTE  AND  BEAUFAY  93 
function is still a matter of controversy (32). 
The dependence of the PGE2 synthesis activity on the concentration of arach- 
idonic acid was biphasic, with a sharp optimum at 25 uM (Fig. 4).  Inhibition at 
higher values may be  linked  to  the  amphipathic  properties  of the  substrate. 
Triton X-100 and Triton X-405 also inhibited the reaction (Table I). 
Under our assay conditions, the rate of PGE2 formation was constant for at 
least  15  min,  and  linearly related  with  the amount of protein  added  to  the 
reaction medium (Fig. 5). 
The properties of the PGEz synthesizing enzymes in cultivated MRP macro- 
phages  are  thus  similar  to  those  reported  for  the  cyclooxygenase-isomerase 
pathway in  studies on  other cells and tissues:  inhibition by indomethacin and 
activation by L-adrenaline and reduced glutathione. Dithiothreitol also inhibited 
the reaction (Table I), whereas EDTA and Ca  ~+ had no effect to speak of (not 
shown). 
The PGE~ synthesis activity decreased rapidly in cytoplasmic extracts kept at 
0°C  in  the medium used  for homogenization and fractionation (Fig.  6).  The 
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FIGURE 4.  Dependence of the PGE= synthesis activity on the concentration of arachidonic 
acid. An M LP fraction (0.08 mg protein) was incubated under the conditions given in Materials 
and Methods, except that the concentration of arachidonic acid was varied to reach the values 
given in abscissa. 
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FIGURE 5.  Kinetics of PGE= synthesis and dependence of the activity on enzyme concentra- 
tion.  PGE2  were  formed  by  incubation of radiolabeled arachidonic acid  with  cytoplasmic 
extracts as described in Materials and Methods. Reactions were run for various times in the 
presence of 0.18 mg protein, or for 15 rain in the presence of various amounts of protein. 94  SUBCELLULAR  LOCALIZATION  OF  PROSTAGLANDIN  E2  SYNTHESIS 
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FIGURE 6.  Decay of PGE2 synthesis activity in cytoplasmic extracts derived from cultivated 
MRP macrophages. A cytoplasmic  extract freshly  prepared in the standard suspension medium 
was divided into two parts. At time 0, one volume of the suspension medium was added to 
one part (©), and one volume of the suspension medium supplemented with 0.30 mg/ml 
catalase was added to the other part (0). Both preparations were stored at 0°C and assayed  at 
the designated times for PGE~ synthesis  activity, under the conditions given in Materials  and 
Methods. Activities  are expressed in percent of the activity measured at time 0 in the absence 
of  added catalase  (0.156 nmol PGE~  formed/rain X mg protein). The half-life  of PGE~ synthesis 
activity  was 1.9 h in the standard medium, and 6.3 h in the presence of 0.15 mg/ml catalase. 
decay was exponential, with a half-life of =2 h. It precluded attempts to investi- 
gate the subcellular distribution unless conditions that better preserve the enzyme 
activity be found. 
Effects of Catalase.  Substances currently used to stabilize cyclooxygenase and 
PGE2 isomerase purified from other tissues, including glycerol, ethyleneglycol, 
EDTA, and glutathione (32, 34, 35) did not give satisfactory results. In contrast, 
catalase augmented noticeably the stability (half-life ---6 h) and to some extent 
the initial activity of the enzyme in cytoplasmic extracts (Fig. 6). 
Although the mechanism through which catalase acts is still unclear, our results 
show that distinct effects enhance the activity and slow down its decay. Indeed, 
the enhancement of PGE2 synthesis was conditioned by the enzyme activity of 
catalase, and did not occur when aminotriazole-inhibited catalase was used (Table 
II). It may be that peroxides are formed in the cell-free extracts and lower the 
PGE~ synthesis activity. Addition of hydrogen peroxide to the reaction medium 
inhibited PGE2  synthesis, and active catalase prevented  this inhibition, at least 
partly (results not shown). The catalase concentration of 0.15 mg/ml was optimal; 
higher values lowered  the activity of PGE2  synthesis. In  contrast,  the  greater 
stability found in  the  presence  of catalase  did not require  the  activity of this 
enzyme. Aminotriazole-inhibited catalase was as powerful as the active enzyme 
in slowing the loss of PGE2 synthesis activity (Table II).  Hemoglobin and, to a 
lesser  extent  cytochrome c,  acted  like  inhibited-catalase,  whereas  superoxide 
dismutase had no perceptible stabilizing effect. 
Density Distribution  of PGE2  Synthesis Activity.  The  combined  protective  and 
activating effects of catalase, jointly with the characteristic of the E-40 rotor to 
equilibrate the organelles rapidly in the gradient (22) made it possible to inves- DARTE AND BEAUFAY 
TABLE II 
Effect of Various Proteins on the Activity and Stability of the PGE~ Synthesis Activity 
95 
Concentration in 
Added protein  storage medium 
PGE2 synthesis  activity 
Initial  After 2 h at 0°C 
mg/ml  pmol/min X mg protein  % 
Expt. I 
None  270  150  56 
Catalase  0.15  460  400  87 
Inhibited catalase  0.15  300  270  90 
Expt. 2 
None  190  70  37 
Cytochrome c  0.5  170  110  65 
Hemoglobin  0.5  200  160  80 
Expt. 3 
None  130  60  46 
Superoxide dismutase  0.2  140  70  50 
Superoxide dismutase  1.0  150  70  47 
The experimental conditions were similar to those described in Fig. 6. PGE~ synthesis activities were 
assayed as described under Materials and Methods immediately after the additions (initial activity) 
and after 2 h storage at 0°C. Catalase was inhibited (>99%) by aminotriazole according to Margoliash 
and Novogrodsky  (33). Percent values refer to initial activities. 
tigate  the  subcellular  distribution  of the  PGE2 synthesis  activity  by  density 
equilibrium  analysis  in  a  linear  gradient  of sucrose.  Cytoplasmic  extracts  of 
cultivated MRP macrophages were prepared and fractionated by centrifugation 
in a  sucrose gradient  in  the  medium  used previously (21),  supplemented  with 
0.15  mg catalase per ml.  The resulting  fractions were assayed immediately for 
PGE2 synthesis activity, and subsequently for a number of reference enzymes. 
The  density distributions  of reference  enzymes are  shown  by solid  lines  in 
separate sections of Fig. 7. They are similar to those obtained after equilibrium 
centrifugation in the absence of catalase (21). Thus, addition of this enzyme had 
no perceptible effect on the density of subcellular components. The distribution 
of PGE~ synthesis activity is given by the shaded histograms  superimposed on 
the density profile of each reference enzyme for the sake of making the compar- 
ison easy. The profile of PGE2 synthesis activity fits fairly well with the distribu- 
tion of sulfatase C, although a slight excess is noted in the high density subfrac- 
tions.  It markedly dissociates from the density patterns  of galactosyltransferase 
and NAD glycohydrolase, which occur in subfractions of lower density, and from 
cytochrome  c  oxidase,  which  shows  a  much  narrower  density  profile.  The 
dissociation from acid 0t-galactosidase is also apparent, although the excess over 
sulfatase C  in high  density subfractions could reflect association of part of the 
PGE2 synthesis activity with lysosomal elements.  As specified in the legends of 
Figs.  7 and  8, the recovery of PGE2 synthesis activity in the gradient  fractions 
was -60%.  Apparently,  the  decay of this  activity was somewhat  faster  in  the 
gradient than in the sample kept to establish the balance sheet. 
Sulfatase C belongs to a group of enzymes associated with subcellular compo- 
nents that show two typical properties in density equilibrium centrifugation:  in 96  SUBCELLULAR  LOCALIZATION  OF  PROSTAGLANDIN  E~  SYNTHESIS 
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FIGURE 7.  Density distribution of PGE~ synthesis activity after isopycnic centrifugation in 
sucrose gradient. Results of two experiments in which cytoplasmic extracts have been layered 
over a  linear gradient of sucrose and centrifuged for density equilibration as described  in 
Materials and Methods and with more experimental details in reference 21.  The frequency 
histograms obtained have been normalized and averaged as described elsewhere (22).  The 
represented portion of the density distribution is divided into 15 fractions of identical density 
increment and extends from 1.10 to 1.27 in density. On the left-hand side of the dashed line 
a tingle block gives the activity found in the sample layer (below 1.1 density units); it has been 
constructed assuming a density increment of 0.03 units. Solid lines give the density distribution 
of reference enzymes specified in each section. These density profiles are compared to that of 
the PGE~ synthesis activity (shading), which is superimposed on each plot. Percentage values 
give the average recoveries of reference enzymes in the gradient fractions. Recovery of PGE~ 
synthesis activity was 55%. 
contrast  to  NAD  glycohydrolase  and  other  enzymes  associated  with  the  cell 
periphery they do not acquire a higher density by treatment with digitonin, but 
they  shift  to  a  lower  density  when sodium  pyrophosphate  has been  added  to 
cytoplasmic  extracts  (21).  Because  the  density  distribution  of  PGE~  synthesis 
activity correlates with sulfatase C in untreated preparations, it was of interest to 
examine  its centrifugation  behavior  in preparations  treated  with digitonin and 
pyrophosphate. Density distributions of reference enzymes were established using 
cytoplasmic  extracts  supplemented  with digitonin  and  sodium  pyrophosphate. 
As expected  from our previous studies (21) the density profiles of NAD  glyco- 
hydrolase  and  sulfatase  C  were  shifted  in  opposite  directions.  The  median 
equilibrium density of NAD glycohydrolase was I. 153 in untreated preparations 
(Fig.  7) and became  1.184 after treatment  (Fig. 8),  whereas that of sulfatase C 
decreased from  1,185 to 1,160 as a result of the treatment.  The behavior of the 
PGE~ synthesis activity was similar to that of sulfatase C, except that some activity 
remained  in  the  high  density  subfractions.  Median  values  of the  equilibrium 
density  were  1,180  and  1,171  in  the  control  and  the  treated  preparation, 
respectively.  Cytochrome  c oxidase was not perceptibly  influenced by the treat- 
ment,  and acid  a-galactosidase  was largely  released  in the suspension  medium DARTE  AND  BEAUFAY  97 
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FIGURE 8.  Density distribution of PGE~ synthesis activity, sulfatase C and NAD glycohydro- 
lase after  treatment with digitonin and pyrophosphate.  The cytoplasmic extract has been 
brought into a medium which contained digitonin and sodium pyrophosphate, as described in 
Materials and Methods, and subsequently layered on a linear gradient of sucrose and centri- 
fuged exactly as in the experiments reported in Fig. 7. Solid lines give the distribution of 
NAD glycohydrolase and sulfatase C; the shading is the distribution of PGE2 synthesis activity. 
Histograms were constructed as described in Fig. 7. Recovery of PGE~ synthesis activity was 
65%. 
(not shown), in agreement with the properties of the mitochondrial and lysosomal 
enzymes reported earlier (21, 27). 
Discussion 
In cell-free extracts derived from MRP macrophages the general properties of 
the enzymes that convert arachidonic acid into PGE2 are similar to those reported 
for the enzymes from several  other sources (36).  In particular  the reaction is 
strongly  inhibited  by  indomethacin  and  activated  synergistically  by  reduced 
glutathione and L-adrenaline. 
The dependency on reduced glutathione is of special interest, because it may 
have a direct physiological significance. Recent work has shown that macrophages 
depleted of intracellular glutathione have a reduced capacity for PGE~ secretion 
(37). This was interpreted as indicating a cofactor role for reduced glutathione 
in PGE~ synthesis by macrophages, by analogy with the properties of enzymes 
from other sources. The finding that reduced glutathione stimulates the PGE2 
synthesis activity in cell-free extracts  from  MRP  macrophages brings a  direct 
support to this view. 
In contrast,  the absolute requirement for L-adrenaline in PGE2 synthesis by 
cytoplasmic extracts  from MRP macrophages reflects the need for a  reducing 
agent  to  convert  PGG2  into  PGH2  through  cyclooxygenase (36).  The  actual 
electron donor in living cells has not yet been identified; L-adrenaline, which acts 
at relatively high concentration under our assay conditions, is likely to be a mere 
substitute. 
Because the PGE2 synthesis activity is labile in cell-free extracts  from MRP 
macrophages, studies on  its subcellular distribution  were  hampered  until  this 
difficulty was largely overcome by addition of catalase to the suspension medium. 
The presence of catalase resulted in a  stimulated activity (by  1.7-fold) in fresh 
homogenates, and in a distinctly greater stability (by more than threefold) of the 98  SUBCELLULAR  LOCALIZATION  OF  PROSTAGLANDIN  E~  SYNTHESIS 
active enzyme.  Our goal was not to elucidate the mechanisms responsible for 
these effects of catalase, which are still unclear. The enhancement of the PGE2 
synthesis activity and its stabilization  are  apparently independent phenomena. 
The former is conditioned by the catalase activity, which suggests that peroxides 
formed in cytoplasmic extracts  from MRP macrophages reversibly inhibit the 
PGE2  synthesis.  According to Hemler and  Lands (38)  hydroperoxides initiate 
the cyclooxygenase reaction, but may also lead to unproductive oxidized forms 
of the enzyme, susceptible to be reduced back to the active form. 
In contrast,  the stabilizing action of catalase is unrelated to its own enzyme 
activity. Amino-triazole-inhibited catalase was as powerful as the active protein 
and  other  hemoproteins,  e.g.  hemoglobin and  cytochrome c,  led to a  similar 
result. Hemoproteins activate  PG endoperoxide synthetase in purified enzyme 
preparations  indirectly,  free  hematin  dissociated  from  hemoproteins  by  the 
interaction of arachidonic acid being then the true activating factor (39).  If a 
loss of heme is involved in the decay of PGE2 synthesis activity in cytoplasmic 
extracts of MRP macrophages, other hemoproteins may have a stabilizing influ- 
ence. This explanation, however, is hardly valid for cytochrome c, in which heme 
is covalently linked to the apoprotein. 
Comparison of the density distributions in a linear gradient of sucrose disclosed 
that PGE~ synthesis behaves like sulfatase C, an enzyme that may be regarded as 
a  reference  for  the  endoplasmic  reticulum  in  MRP  macrophages  (21).  The 
distribution of PGE2 synthesis activity clearly differed from those of galactosyi- 
transferase, cytochrome c oxidase, and NAD glycohydrolase, which are essentially 
associated with the Golgi apparatus,  mitochondria, and plasma membrane, re- 
spectively. Thus, we have found no evidence in favor of a  plasma membrane- 
associated  activity,  postulated  recently  (40)  to account  for  the  metabolism of 
exogenously supplied arachidonic acid into oxygenated products by MRP mac- 
rophages.  Because catalase  was added to the sucrose solutions making up the 
gradient it was not possible to compare the distribution of PGE~ synthesis activity 
with that of the catalase-bearing organelles identified recently in these cells (21). 
Nevertheless, judging  from  the  behavior  of the  endogenous catalase  in  our 
earlier  experiments,  the  PGE2  synthesis activity  cannot  be  assigned  to  these 
organelles. The distributions shown in Figs. 7 and 8 also dissociate the bulk of 
this activity from lysosomes. Indeed, the density distribution of acid a-galactosid- 
ase  is  not  perturbed  like  that  of  enzymes  associated  with  the  endoplasmic 
reticulum when cytoplasmic extracts are treated with pyrophosphate (21). How- 
ever,  the presence of some activity in excess over that of sulfatase  C  at high 
density values makes it possible that a  small part of the PGE~ synthesis activity 
be associated with lysosomes, or related vacuoles. 
These conclusions suffer from two limitations that must be briefly examined. 
First, the recovery of the PGE~ synthesis activity in the density gradient fractions 
was consistently around 60%,  even though the experimental design takes  the 
loss of enzyme activity during the time of centrifugation into account. Conceiv- 
ably, a  pool of enzyme especially labile could have a  distinct subcellular distri- 
bution undetectable in our experiments. This assumption is not consistent with 
the finding that the loss of activity in cytoplasmic extracts follows a simple first- 
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Another limitation is that the activity detected in our assays of PGE2 synthesis 
involves two enzymes acting  successively, cyclooxygenase and  PGE  isomerase 
(41). These enzymes could be associated with distinct subcellular components. If 
one  of  the  reactions  is  sharply  rate-limiting  in  the  cytoplasmic  extract,  its 
distribution  in  the  gradient  cannot  markedly  differ  from  that  found  when 
arachidonic acid is transformed into PGE2, and our conclusion is valid for the 
rate-limiting enzyme. Otherwise, the PGE2 synthesis activity would be found in 
the fractions in which the distributions of cyclooxygenase and isomerase overlap, 
and the correlation between its density profile and that of sulfatase C could be 
nothing but a coincidence. This possibility seems unlikely because the correlation 
persists  after  treatment  of the  cytoplasmic  extracts  with  pyrophosphate  and 
digitonin.  The  only  subcellular  components known  to  be  perturbed  in  their 
density distribution  by  these agents derived  from the  plasma  membrane and 
from the endoplasmic reticulum (21), and they are shifted in opposite directions. 
Thus, the joint shifts of PGE~ synthesis activity and of sulfatase C shows that at 
least the rate-limiting enzyme reaction in the transformation of arachidonic acid 
into PGE2 is associated with the endoplasmic reticulum membranes. 
The various phenomena that surround the synthesis of PG by macrophages 
include the triggering events, the release of free arachidonic acid from phospho- 
lipids by phospholipase(s), and the oxygenation and isomerization reactions that 
convert arachidonic acid into PGE~. In connection with other studies our results 
emphasize the fact that they involve several distinct organelles of the cell, at least 
the plasma membrane and the endoplasmic reticulum. 
It is well established that the binding of immune complexes to Fc receptors of 
the plasma membrane of MRP  macrophages is a  sufficient stimulus and  that 
phagocytosis of the complexes is not a prerequisite for synthesis of PGE~ to occur 
(19, 20). In addition, the plasma membrane Fc3, receptor for IgG2b of a murine 
cell line possesses an intrinsic phospholipase A~ activity that is expressed concom- 
itantly with the release of PGE2 after binding of IgG2b (42, 43). The subcellular 
source of the phospholipids that supply the phospholipase-cyclooxygenase system 
with arachidonic  acid  is still  uncertain,  but  the association of PGEu  synthesis 
activity with endoplasmic reticulum membranes, rather than with plasma mem- 
branes,  implies some kind of cooperation between distinct entities of the cell. 
Earlier  studies  by  Brune  et  al.  (20)  have  revealed  that  there  is  a  striking 
coincidence of the PG release and the formation of large cytoplasmic vacuoles 
in  macrophages,  even  when  secretion  of  PG  is  induced  in  the  presence  of 
cytochalasin  B,  which  inhibits  phagocytosis.  It  was  envisaged  that  fusion  of 
different membranes brings the phospholipids in contact with the enzymes of 
the PG synthesis pathway. This concept is still a reasonable hypothesis for future 
work.  Alternatively, phospholipids and/or arachidonic acid and its derivatives 
could be exchanged by specific carrier proteins analogous to the phosphatidyl- 
choline exchange protein identified in liver cells (44). 
Summary 
The aim of this work was to establish, on a quantitative basis, the subcellular 
distribution of the enzyme system that converts arachidonic acid into prostaglan- 
din (PG) E2 in mouse resident peritoneal  (MRP)  macrophages. Kinetic studies 100  SUBCELLULAR  LOCALIZATION OF PROSTAGLANDIN E2  SYNTHESIS 
were conducted on cell-free extracts derived from cells cultivated for 1 d, using 
[1-14C]arachidonic  acid  as  substrate  and  measuring  the  label  in  PGEe  after 
extraction  and thin  layer chromatography.  The activity was synergistically en- 
hanced by L-adrenaline and reduced glutathione, inhibited by indomethacin, and 
linearly related to the concentration of the cell-free extract. It was labile at 0°C 
in the medium used for homogenization and fractionation of the cells (half-life 
<2  h).  Addition  of catalase (0.15  mg/ml) to the suspension medium increased 
the initial activity (by ---70%) and the stability (half-life ---6 h) of the enzyme in 
cytoplasmic  extracts.  It  enabled  us  to  establish  the  density distribution  after 
isopycnic centrifugation in a linear gradient of sucrose. The sample centrifuged 
consisted of untreated cytoplasmic extracts, or cytoplasmic extracts treated with 
digitonin and Na pyrophosphate. Comparison of the centrifugation behavior of 
PGE2 synthesis activity with that  of various enzymes used as reference for the 
major subcellular entities has revealed that PGE2 synthesis fairly fits the density 
profile of sulfatase C in each case. The conclusion is that at least the rate-limiting 
reaction  in  the  conversion  of arachidonic  acid  into  PGE2  is  catalyzed  by an 
enzyme associated with the endoplasmic reticulum. 
We gratefully acknowledge the expert technical assistance of Beatrice Paulus-Clotuche. 
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